Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 4
2007 1
2010 3
2016 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2- Advanced Breast Cancer Patients: An Italian Managed Access Program.
Staropoli N, Geuna E, Rinaldi G, Bisagni G, Scotti V, Faggioni G, Vannini L, Arcara C, Moretti G, Gunnellini M, Coltelli L, Verderame F, Livi L, Sanna G, Grasso D, Abbinante G, Ragni F. Staropoli N, et al. Among authors: arcara c. Curr Oncol. 2022 Sep 17;29(9):6635-6641. doi: 10.3390/curroncol29090521. Curr Oncol. 2022. PMID: 36135090 Free PMC article.
Breakthrough pain in oncology: a longitudinal study.
Mercadante S, Zagonel V, Breda E, Arcara C, Gebbia V, Porzio G, Aielli F, David F, Gammucci T, Narducci F, Lanzetta G, Restuccia R, Lembo A, Passeri V, Virzì V, Casuccio A. Mercadante S, et al. Among authors: arcara c. J Pain Symptom Manage. 2010 Aug;40(2):183-90. doi: 10.1016/j.jpainsymman.2010.01.010. Epub 2010 May 5. J Pain Symptom Manage. 2010. PMID: 20447801 Free article.
Tumor markers in urogynaecological tumors.
Leto G, Incorvaia L, Badalamenti G, Arcara C, Fulfaro F, Tumminello FM, Flandina C, Crescimanno M, Gebbia N. Leto G, et al. Among authors: arcara c. Tunis Med. 2005 Dec;83 Suppl 12:28. Tunis Med. 2005. PMID: 16430064 Review. No abstract available.
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety.
Valerio MR, Arrivas Bajardi E, Arcara CC, Borsellino N, Lo Mauro M, Cipolla C, Santarpia M, Firenze A, Motta G, Vigneri P, Gebbia V. Valerio MR, et al. Among authors: arcara cc. Am J Clin Oncol. 2021 Mar 1;44(3):105-108. doi: 10.1097/COC.0000000000000790. Am J Clin Oncol. 2021. PMID: 33481372
16 results